Bayer AG has reached a $6.9 million settlement with New York for allegedly making false and misleading claims regarding the safety of Roundup weedkillers, the state's Attorney General Letitia James said on Thursday.
British drugmaker AstraZeneca said on Thursday it would stop developing its drug brazikumab to treat inflammatory bowel diseases, including Crohn's disease and ulcerative colitis.
Swiss agrichemicals group Syngenta on Thursday reported higher first-quarter sales and profit, having passed on higher costs to farmers buying its seeds and sprays.
GSK Plc will buy Canada-based late-stage biopharma firm Bellus Health Inc in an all-cash deal for $2 billion, the companies said in a joint statement on Tuesday. (Reporting by Aby Jose Koilparambil in Bengaluru; Editing by Savio D'Souza)